Development of a Gaussian Process – Feature Selection Model to Characterise (poly)dimethylsiloxane (Silastic®) Membrane Permeation by Sun, Yi et al.
Development of a Gaussian Process – feature selection
model to characterise (poly)dimethylsiloxane (Silastic)
membrane permeation
Yi Suna, Mark Hewittb, Simon C. Wilkinsonc, Neil Daveya, Roderick G. Adamsa, Darren R. Gullickd,*
and Gary P. Mosse
aSchool of Computer Science, University of Hertfordshire, Hatfield, bSchool of Pharmacy, University of Wolverhampton, Wolverhampton, cSchool
of Biomedical, Nutritional and Sports Sciences, Medical School, University of Newcastle-upon-Tyne, Newcastle-upon-Tyne, dSchool of Pharmacy &
Biomedical Sciences, University of Portsmouth, Portsmouth, eThe School of Pharmacy, Keele University, Keele, UK
Keywords
data set design; feature selection; Gaussian
Process Regression; machine learning;
polydimethylsiloxane
Correspondence
Gary P. Moss, The School of Pharmacy,
Keele University, Keele, Staffordshire ST5
5BG, UK.
Email: g.p.j.moss@keele.ac.uk
Received January 17, 2020
Accepted March 8, 2020
doi: 10.1111/jphp.13263
*Present address: ETS Laboratories, Saint
Helena, CA, 94574, USA
Abstract
Objectives The current study aims to determine the effect of physicochemical
descriptor selection on models of polydimethylsiloxane permeation.
Methods A total of 2942 descriptors were calculated for a data set of 77 chemi-
cals. Data were processed to remove redundancy, single values, imbalanced and
highly correlated data, yielding 1363 relevant descriptors. For four independent
test sets, feature selection methods were applied and modelled via a variety of
Machine Learning methods.
Key findings Two sets of molecular descriptors which can provide improved
predictions, compared to existing models, have been identified. Best permeation
predictions were found with Gaussian Process methods. The molecular descrip-
tors describe lipophilicity, partial charge and hydrogen bonding as key determi-
nants of PDMS permeation.
Conclusions This study highlights important considerations in the development
of relevant models and in the construction and use of the data sets used in such
studies, particularly that highly correlated descriptors should be removed from
data sets. Predictive models are improved by the methodology adopted in this
study, notably the systematic evaluation of descriptors, rather than simply using
any and all available descriptors, often based empirically on in vitro experiments.
Such findings also have clear relevance to a number of other fields.
Introduction
Predicting the permeation into and across the skin of
exogenous chemical is of substantial interest for a number
of industries, including pharmaceuticals, cosmetics, pesti-
cides and the handling of industrial chemicals. Determining
skin permeability is therefore an essential component of
understanding the risks associated with exposure of the
skin to exogenous chemicals. In general, in vitro experi-
ments form a significant part of early-stage evaluation of
pharmaceutical formulations or in risk assessment proto-
cols for other topical exposures. While fresh human skin is
the perceived ‘gold standard’ for in vitro testing, its consis-
tent use is constrained by availability, which often means
that certain compromises are commonly adopted,
including the use of previously frozen human skin and tis-
sue from other species; in the latter case, it is generally
accepted that pig skin is the best model for human skin,
with the pig ear being widely used despite differences in the
lateral packing of stratum corneum lipids, compared to
human skin.[1-4]
Given the scientific and logistical constraints discussed
above, artificial membranes have also found widespread use
in early-stage assessment of percutaneous absorption, nota-
bly in the context of formulation optimisation and elucida-
tion of permeation mechanisms. Polydimethylsiloxane
(PDMS, Figure 1) is one of the most widely used mem-
branes in such studies and has been shown to correlate well
with mammalian skin studies[5] but differences in the dis-
tribution of permeation compared to mammalian skin have
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also been found.[6,7] Similarly, Gullick and co-workers
found reasonable correlations between in vitro diffusion
experiments using PDMS membranes and pig skin.[8]
PDMS has also been widely used to investigate mechanisms
of membrane transport. Permeability was generally related
to the physicochemical properties of their penetrants, and
solvents were taken up into the membrane, altering mem-
brane properties and the flux of the permeants.[9-12] ATR-
FTIR spectroscopy has also been used to evaluate diffusion
across a PDMS membrane[13] with a rudimentary struc-
ture–activity relationship for permeability across a PDMS
membrane being developed.[14] It was also reported that
the permeation distribution of a range of chemicals across a
PDMS membrane was Gaussian-normal,[15] in contrast to a
number of studies which reported non-Gaussian (log-nor-
mal) distribution in mammalian skin.[6,9,16-21] This differ-
ence was broadly attributed to the heterogeneity of
biological membranes, including the possibility of multiple
permeation pathways in mammalian skin, which is in con-
trast to the homogeneity of PDMS membranes. PDMS
membranes are therefore pharmaceutically significant and
provide an effective screen in early-stage formulation devel-
opment and in the elucidation of mechanistic information
for the permeation process.
The first major studies quantifying permeability across
a PDMS membrane initially saw the development of
empirical models for permeation across a PDMS mem-
brane which related flux through the membrane to partial
atomic charge, mole fraction solubility and molecular
weight.[22]:
log Jmss ¼ 2:497 4:339Reþ  1:531Re
þ 4:065ðReþ:RepÞ þ 0:649 logCS
 0:00651MW 0:640imidazoleþ 0:689amine
ð1Þ
n = 103, r2 = 0.966, s = 0.238, F = 386.5; where Jmss is
the maximum steady-state flux (lmol/s per cm2); Σe+ is
the sum of the charge values of hydrogen atoms (with
charge >0.1) and the positive charge of a nitrogen atom
in a nitro group; Σe is the sum of the absolute charge
values of all other heteroatoms with unshared electron
pairs in the same molecule.
Equation 1 gave better predictions than their previous
model, and they applied it to predict the flux of 171 new
compounds which were not included in their previous
study.[23] This yielded a slightly simplified model which
omitted the imidazole descriptor:
log Jmss ¼ 2:497 4:339Reþ  1:531Re
þ 4:065ðReþ:ReÞ þ 0:649 logCs
 0:00651MWþ 0:689amine
ð2Þ
These data[22,23] were re-analysed with the aim of devel-
oping a QSAR model based on readily calculable descrip-
tors, unlike those used in the original studies, with greater
mechanistic insight for the whole data set.[24] This resulted
in a simple QSAR:
log J ¼ 0:561HA0:671HD 0:8016v0:383 ð3Þ
n = 242, r = 0.900, s = 0.464, F = 338; where J is the
steady-state flux (lmol/s per cm2), HA and HD are,
respectively, the number of hydrogen bond acceptor and
donor groups present on a penetrant and 6v is the sixth-
order path molecular connectivity.
This model describes permeability across a PDMS mem-
brane in terms of hydrogen bonding and molecular topol-
ogy. These data[22-24] were also modelled by in an artificial
neural network (ANN) study.[25] They generated a 12-pa-
rameter non-linear QSAR model which, most significantly,
found that log P was not significant, being attributed to the
inability of log P to account for intramolecular interactions.
Similar findings were also reported[26] although these were
based on a very small data set (n = 16). In more recent
years, Gaussian Processes Regression methods (GP, or
GPR) have been shown to outperform QSARs in predicting
the skin permeability of compounds.[27] GPs have recently
been used for the prediction of the permeability of com-
pounds across non-human skin and synthetic poly-
dimethylsiloxane membranes,[28,29] and human skin.[30]
Two of the major problems with developing valid and
useful models of biological functions, such as skin perme-
ability, are the selection of appropriate descriptors (fea-
tures) and the size of the data set. The impact for a small
data set may be more prominent as the solution (the set of
selected descriptors) may change more significantly if one
data point is replaced by another. These issues have been
addressed in recently,[30-32] resulting in the models that are
highly predictive and robust.
It is clear that a number of previous studies in this field
focus on using existing data or collating as much available
data as possible and that the descriptors of interest are often
chosen based on empirical studies. Such approaches limit
the value of models, and while a detailed understanding of
data set size and distribution has been addressed previ-
ously,[32] this study focuses on the selection of objective rel-
evant physicochemical descriptors, employing a Feature
Figure 1 Chemical structure of (poly)dimethylsiloxane (PDMS).
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Selection methodology to do so. Therefore, the two aims of
this work were, firstly, to find a set of highly relevant
molecular descriptors that describe the process of mem-
brane permeation and, secondly, to determine whether fea-
ture selection techniques can yield benefits in the
prediction of chemical transport across PDMS membranes
and to provide a more specific and nuanced understanding
of the mechanistic nature of the permeation process. The
novelty of this work is that this is the first time such
methodology (that is, feature selection on a small data set
with a large number of physicochemical descriptors) has
been applied to a system of pharmaceutical interest and this
clearly has implications for other permeation across other
membranes, notably skin.
Methods
Description of the data set
A human skin data set was not used in this study due to pre-
viously reported inconsistencies in the available data,[33-35]
which it was felt could inhibit the development of new models
based on the approach used in this study. Thus, a PDMS
membrane was considered more appropriate as its use is gen-
erally associated with a greater consistency.[22-24,36] The data
set was collated from the existing scientific literature and is
available as Appendix S2. It consists of 77 unique chemical
compounds. For each compound, the permeability coeffi-
cient, kp(cm/h), across a PDMS membrane was used and
2942 physicochemical descriptors were determined using a
range of software packages (Dragon Professional, Molecular
Operating Environment (MOE), HYdrogen BOnd Thermo-
dynamics (HYBOT) and WinMolconn). While it is more
common to use flux (J) to describe membrane perme-
ation,[22-24] the permeability coefficient, kp, which is effectively
the concentration-corrected flux, is more widely used in the
scientific literature and, notably, in the construction of skin
permeation models. This is because the use of kp allows a
comparison to be made between different chemicals as con-
centration differences are generally accounted for.[36-38]
Data set pre-processing
There are no missing values or inconsistent data in the data
set used in this study. 772 descriptors had only one possible
value and were removed from the data set. A further 194
descriptors were removed as their distributions were highly
imbalanced (i.e., the number of one certain value is greater
than a threshold set in this analysis, i.e. 90% or greater of
the total number of data points). 613 further descriptors
which were highly correlated within the data set (i.e. those
whose correlation coefficients are greater than 0.99) were
removed. The analysis in this study was conducted on a
refined data set of 77 compounds, each with 1363 physico-
chemical descriptors.
Generation of four independent test sets
It has been demonstrated previously that there are no sig-
nificant linear relationships with the target permeability
data for the descriptors used.[37,39] Principal component
analysis (PCA) indicated that no linear relationship was
observed between the permeability coefficient and the com-
pound descriptors combined in the first component, where
40.2% of the variance was due to the first two principal
components, PC1 and PC2. Figure 2 shows a PCA plot of
the original, complete, PDMS data set, indicating that the
first two Eigenvectors capture 40.21% of the total data vari-
ance. In order to observe how the final selected descriptor
set affects the performance of regression models on the test
set, four different test sets were randomly constructed, each
of which includes seven test compounds:
• Set A – seven test compounds were selected from the
boundary of the data cloud shown in the PCA (Figure 3a
for PC1, and Figure 3b for PC2, denoted by crosses, ‘+’
in these figures). These PCA plots further show the rela-
tionship between logKp and the first two principal com-
ponents, indicating that, except for the selected
compound with the largest logKp value and the two
selected compounds with relatively small logKp values,
the remaining four selected compounds, compounds
with different PC projections but very similar logKp val-
ues can be found. This test set is denoted TstA and the
rest of the chemical compounds as TrnA.
• Set B – this test set includes the three smallest and the
four largest logKp values. Figure 3c,d shows projections
of these compounds on a PCA plot for PC1 and PC2,
respectively; this test set is denoted as TstB and the rest of
the chemical compounds as TrnB.
• Set C – seven compounds randomly selected from the
data set. Figure 4a,b shows the projections of these com-
pounds in the PCA plot for PC1 and PC2, respectively.
This test set is denoted as TstC and the remaining chemi-
cal compounds as TrnC.
• Set D – seven compounds selected from the t-sne plot[40] and
for PC1 and P2 is shown in Figure 4c,d, respectively. This is
denoted as TstD and the rest of the chemicals as TrnD.
Constructing random training/validation
sets
To obtain robust results for each training set the data has
been shuffled 10 000 times. Each shuffle sees 60 chemicals
randomly selected as the training set of regression models
and the remaining compounds are used as the validation
© 2020 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 72 (2020), pp. 873–888
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set.[28-32,37,39] Thus, there are 10 000 training subsets and
10 000 validation sets corresponding to each training set.
The validations sets are used for feature selection rather
than hyperparameter tuning. In using such a method,
descriptors selected from different training sets will vary
and those that are consistently selected are of most interest.
The standard deviation is also used to describe the variance
of the outputs.
Methods of analysis
In this study, a range of methods were used. These methods
are outlined below; they have been reported on extensively
previously[30-32,37,39,41-59] and detailed methods are also
included as Appendix S1.
Random Forest Trees (RFTs)
The Random Forests algorithm was coupled with the ran-
dom selection of descriptors and bootstrap aggregation to
the training sets.[52] In this study, an ensemble of decision
trees for regression has been applied via MatLab TreeBag-
ger. The 50 most important descriptors in each ensemble of
decision trees for a given training set were identified. Thus,
either a trained RFT or GP model has been developed using
the most relevant physicochemical descriptors only. While
normally it would not be necessary to have a validation set
for the RFT experiments, we have, in this case, used a vali-
dation set in order to keep our results consistent with the
other tests used in this study.
LASSO
In this study, the LASSO method[54] has been applied, with
a five-fold cross-validation method, in order to remove
redundant descriptors from the data set. To speed up the
processing time the UseParallel mode has been enabled. All
other parameters are set to the default mode in MATLAB.
(Joint) Mutual Information (MI, JMI)
In this study, the MatLab FEAST toolbox (http: www.cs.ma
n.ac.uk/gbrown/fstoolbox) has been used to select descrip-
tors using the JMI criterion by assigning labels to the
responses required by the model. Those responses have
been aligned into 10 categories.
Gaussian Processes
A Gaussian Process (GP) is defined as a collection of ran-
dom variables which, jointly, have a Gaussian distribu-
tion.[57] GPs have also been successfully applied to the field
of predicting percutaneous absorption.[30-32,37] GP meth-
ods have been described in detail previously and are also
discussed in the Appendix S1.
Figure 2 A principal component analysis plot of the original PDMS data set, showing that the first two Eigenvectors capture 40.21% of the total
variance. [Colour figure can be viewed at wileyonlinelibrary.com]
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Figure 3 Boundary points in the principal component analysis plot shown for (a) PC1 and (b) PC2 for Test Set A, and with the three smallest logKp val-
ues and four largest logKp values highlighted for (c) PC1 and (d) PC2 for Test Set B. [Colour figure can be viewed at wileyonlinelibrary.com]
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Figure 4 Principal component analysis plots for Test Sets C, showing seven compounds randomly selected from the data set for (a) PC1 and (b)
PC2, and for Test Set D showing seven compounds selected from the t-sne plot,[40] for (c) PC1 and (d) PC2. [Colour figure can be viewed at
wileyonlinelibrary.com]
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Automatic Relevance Determination
To implement automatic relevance determination (ARD)
in a GPR, the characteristic length scale matrix, M, is rede-
fined as a diagonal matrix containing the elements of vector
L ¼ l21 ; . . .; l2D
 
and l1; . . .lD on the diagonal are the char-
acteristic length scales for each input dimension, determin-
ing how relevant an input is to the task. These
characteristic length scales can be optimised from the data
by Bayesian inference.
Performance measures
The mean squared error (MSE), improvement over Na€ıve
model (ION) and the Pearson correlation coefficient (r, or
CORR) we are all used to evaluate the performance of each
model.[30-32,37,39,59] MSE measures the average squared dif-
ference between model predictions and the corresponding
targets. The ION measures the degree of improvement of
the model performance over the performance of the Na€ıve
predictor, which is normally the mean of the output (e.g.
logKp) in the training set. The ION is thus defined as:
ION ¼ MSENaive MSE
MSENaive
 100% ð4Þ
CORR measures the correlation between predictions and
targets. For comparison, a ‘good’ model should have a low
value of MSE and high values of ION and CORR on a given
test data set.
Results and Discussion
In this field, it is important to note that previous studies
are either based on small data sets (e.g. 16 chemicals of lim-
ited structural diversity[26]) or on different experimental
conditions (e.g. an isopropylalcohol solvent system at
30°C[22-24]). Benchmarking is therefore a challenge, and the
decision to focus on a skin permeation QSAR[60] is limited,
but offers a relevance in terms of comparison of PDMS rel-
evance to skin.[39] A consideration of the ION values
between the models and the benchmark suggests a limited
ability of data from PDMS membranes to successfully
model skin, and vice versa, emphasising the limitations of
the PDMS membrane in acting as a substitute for skin.
Table 1 also shows the results of applying GP models.[30,31]
to these data and does so using the same parameters as the
QSAR model in order to provide a comparable benchmark
as well as a full set of 1363 descriptors. While it is usual for
two-thirds of the data set to be used for training and the
remaining one-third for the test in this work, in aiming to
train the model with as many data points as possible and to
repeat this 10 000 times to address concerns of inherent
variance, we aimed for 10% test data, keeping most data in
the training set so the estimates of permeability were as
accurate as possible. We were concerned that if we removed
more data from the training set the predictions would be
significantly impaired, a finding which was apparent in pre-
vious work with similar types of data.[32,61,62]
We have previously used several measures of model qual-
ity, including MSE and ION, rather than just the correlation
coefficient.[28-30,37] This is important because in this study
(e.g. Table 1) it is clear that the QSAR models have the low-
est ION values but reasonably high correlation coefficients,
suggesting a possible systematic error. The GP models have
comparability improved ION values. It is interesting to note
that the MSE and ION results are better than for the QSAR
model but still very poor for the correlation coefficients. This
might reflect the somewhat comparable nature of the linear
QSAR model with the experimental findings that associate
permeation across a PDMS membrane to be predominately
linear – thereby over-estimating permeability particularly at
high lipophilicities. This is not reflected in the GP models
which are more reflective of the non-linear nature of skin
permeability in the context of molecular descriptors such as
log P and molecular weight.[37] It also highlights the limita-
tions of replacement membranes – in this case, PDMS and
mirrors similar outcomes reported previously for a range of
mammalian species.[39]
It should also be noted that the results for the GP models
shown in Table 1 do indicate that ION and MSE values are
significantly better for these models, even if the variance asso-
ciated with each outcome is large when the full set of descrip-
tors is used. This suggests that the full set of descriptors is
responsible for noise and redundancy within the data, high-
lighting the importance of selecting the correct descriptors as
well as the need to rationalise and optimise the descriptors
used for our models in order to produce more accurate esti-
mations of membrane permeability. Further, the ION values
are comparable to those for the correlation coefficient and
provide similar measurements of model quality. This is
important as it allows readers from different disciplines to
frame the outcomes of this study in their own contexts.
Table 2 summarises the results of the first set of
experiments on the PDMS data set. These results indi-
cate that the best overall model is found using the Ran-
dom Forests method, which outperforms other models
for three of the four validation sets – the Mutual Infor-
mation method performs better on validation set D.
This is most likely because the Random Forests method
embeds feature selection methodology in regression. It
was also found that the results of the LASSO method
were not stable and that the mean values of estimations
on two validation sets – A and C – were worse than the
na€ıve predictions. Further, when the GPARD + Full
method is compared to GP it was observed that the use
© 2020 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 72 (2020), pp. 873–888
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of ARD gives much better results. For example, all IONs
of GPARD + Full are greater than 10%, whereas all ION
values in Table 1 are around zero (for the GP method
using the full feature set). This is because, rather than
using an identical length scale over all features and
treating all features equally, GPARD uses a different
Table 1 Results on data sets with two features (MW and log P) using (a) the benchmark QSAR model of Potts and Guy for skin[60]; (b) the Gaus-
sian Process Regression model with two descriptors (MW and log P) and (c) the Gaussian Process Regression model with the full set of descriptors.
Results are the mean value and standard deviation over 10 000 validation sets, which are denoted as ValA, ValB, ValC and ValD, respectively
ValA ValB ValC ValD
QSAR model
MSE 15.98  1.61 16.23  1.89 16.07  2.22 16.31  1.70
ION% 627.35  507.95 871.35  555.31 544.81  405.01 683.68  527.58
CORR 0.55  0.32 0.66  0.25 0.57  0.29 0.62  0.35
Gaussian Process model with two descriptors
MSE 3.13  2.32 1.76  1.61 3.84  2.58 2.64  1.78
ION% 6.20  62.70 22.36  85.27 3.73  53.42 9.76  45.79
CORR 0.37  0.46 0.59  0.35 0.34  0.41 0.39  0.31
Gaussian Process model with full descriptors
MSE 3.25  1.83 2.32  1.27 3.56  2.01 2.95  1.73
ION% 0.00  0.03 2.04  9.01 0.02  0.10 0.08  0.74
CORR 0.12  0.43 0.21  0.37 0.21  0.30 0.36  0.13
QSAR is quantitative structure–activity relationship, and the term QSPR (quantitative structure–permeability) relationship is often interchangeably
used in modelling studies of skin permeation; MSE is mean squared error; ION, or ION%, is the improvement over the na€ıve model; CORR, or r, is
the correlation coefficient; MW is molecular weight; log P is the octanol : water partition coefficient. Results highlighted in bold are those which
achieved the best outcome for each test.
Table 2 Summary of the statistical measures for the validation sets used to assess model quality for the PDMS data set. The results are pre-
sented as (a) MSE; (b) ION and (c) the correlation coefficient
ValA ValB ValC ValD
MSE
RFTs + RFTs 2.46  2.06 1.49  1.50 2.84  2.12 1.82  1.93
GP + RFTs 2.86  1.99 2.22  1.43 3.43  2.22 1.65  1.80
Lasso + Lasso 5.70  223.31 1.64  1.64 3.85  2.50 2.33  2.05
GP + Lasso 3.65  8.03 2.06  1.74 3.90  2.84 2.33  2.27
GP + MI 2.56  2.01 2.51  1.33 3.56  2.08 1.42  1.54
GPARD + Full 2.68  1.96 1.98  1.64 3.38  2.16 2.30  1.64
GP + two fs 3.25  1.83 2.32  1.27 3.56  2.01 2.95  1.73
ION
RFTs + RFTs 30.17  33.50 44.43  34.64 30.74  31.83 49.18  32.27
GP + RFTs 12.09  42.79 4.22  44.44 12.48  39.91 47.32  49.23
Lasso + Lasso 60.94  4.75 35.85  60.29 2.21  62.41 22.51  71.99
GP + Lasso 17.89  187.64 7.60  88.89 2.86  72.57 21.89  80.90
GP + MI 26.42  38.7 13.92  56.41 6.94  36.80 52.32  46.38
GPARD + Full 18.22  40.83 21.80  41.17 13.30  41.09 23.09  36.14
GP + two fs 0.00  0.03 2.04  9.01 0.02  0.10 0.08  0.74
Correlation coefficient
RFTs + RFTs 0.57  0.27 0.66  0.28 0.57  0.26 0.68  0.27
GP + RFTs 0.46  0.26 0.41  0.27 0.45  0.27 0.71  0.25
Lasso + Lasso 0.35  0.30 0.66  0.29 0.41  0.31 0.62  0.29
GP + Lasso 0.41  0.32 0.58  0.28 0.45  0.33 0.61  0.31
GP + MI 0.56  0.25 0.25  0.22 0.41  0.24 0.75  0.22
GPARD + Full 0.47  0.29 0.49  0.31 0.43  0.29 0.53  0.23
GP + two fs 0.12  0.43 0.21  0.37 0.21  0.30 0.36  0.13
PDMS is polydimethylsiloxane (see Figure 1); RFT is random forest tree; GP is Gaussian Process, often used interchangeably with Gaussian Process
Regression (GPR); LASSO is the least absolute shrinkage and selection operator; MI is mutual information (note that JMI, joint mutual information,
has also been discussed in this study); GPARD is Gaussian Process Regression; GP + two fs is the Gaussian Process model run with two descriptors,
log P and MW, to mimic the descriptors used in common QSAR models of skin permeation; Full refers to studies run with the full data set. Results
highlighted in bold are those which achieved the best outcome for each test.
© 2020 Royal Pharmaceutical Society, Journal of Pharmacy and Pharmacology, 72 (2020), pp. 873–888
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length scale for each feature to indicate the importance
of each feature in its predictive ability.
Figure 5a firstly shows that the benchmark QSAR models
perform worst among all the models, which might be
expected based on the above discussion and may reflect
more widely the value of PDMS as an alternative to mam-
malian tissue.[39] Figure 5b shows the mean values of ION,
and it can be seen that there is no improvement if the GP
model is used with the full data set compared to the na€ıve
model. Interestingly, in Figure 5c the corresponding stan-
dard deviation is consistently low over all four validation
sets, suggesting that the full feature data set contains a sub-
stantial amount of noise. Figure 5b also indicates that the
performance of the LASSO models varies across the four
validation sets; they are better than the na€ıve model for two
data sets (A and C) and worse for the other two. RFTs give
better results than the na€ıve model for all four validation
sets. The value obtained using GP with the full feature
selection set is the lowest for all sets of data. The QSAR
models yields relatively good correlation coefficients, which
addresses the issues described above and also previously in
attempting to demonstrate the potential of the PDMS
membrane to represent human skin.[39] Moreover, it
indicates that use of the correlation coefficient alone – as is
often the case in skin permeability studies – may not be a
reliable indicator of model performance and that use
and consideration of a series of statistical measures may
provide more suitable outcomes in terms of describing
model quality.
A small number of descriptors were repeatedly found in
at least 5000 of the repeated experiments. The features
selected using RFTs are shown in Table 3. From this
Figure 5 Overview of the outcome of statistical measures (MSE, ION and correlation coefficient) for the different QSAR and Machine Learning
methods investigated. Results are shown as the mean and standard deviation following 10 000 repetitions of the validation set and presented as
mean and standard deviation; (a) the grouped bar plot of mean values of MSE, with error bars also shown on the plot; (b) the mean values of
ION, with the standard deviations of ION shown in (c) for clarity and (d) the grouped bar plot of mean values of correlation coefficients with error
bars shown on the plot. [Colour figure can be viewed at wileyonlinelibrary.com]
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analysis six common features have been identified from all
four training sets, namely: log P(o/w), PEOE_VSA_FPOS,
Q_VSA_FPOS, CHssNH, Sum(Ea)Alpha and Sum(Cad).
Furthermore, between 28 and 39 features have been selected
from each training set using MI. Seven common features
were identified, namely b_IrotR, b_rotR, log P(o/w), Q-
VSA_FPPOS, vsurf_A, Max(Ea)*Max(Ed) and Sum(Ea)/
Alpha. These descriptors are defined in Table 3 but, in gen-
eral, they fall under three main categories in that they
describe lipophilicity, partial charge and hydrogen bonding
as key determinants of PDMS permeation. This is consis-
tent with many previous findings in this field.[59,63,64] but
Table 3 Lists of physicochemical descriptors selected using RFTs method. The descriptors listed are those chosen more than 5000 times
Training
set Feature list Software Definition
TrnA log P(o/w) – The logarithm of the octanol-water partition
Sum(Ea)/Alpha HYBOT Hydrogen bonding descriptor – Ea factor value per unit of molecular volume
CHssNH MolconnZ Molecular connectivity descriptor
PEOE_VSA_FPOS MOE Partial charge descriptors – Fractional positive van der Waals surface area. This is the sum of the vi
such that qi is non-negative divided by the total surface area. The vi are calculated using a connection
table approximation.
SHCsatu MolconnZ E-State of Csp3 bonded to unsaturated C atoms
GGI6 Dragon Topological charge index of order 6
Q_VSA_FPPOS MOE Partial charge descriptors – Fractional negative van der Waals surface area. This is the sum of the vi
such that qi is negative divided by the total surface area. The vi are calculated using a connection
table approximation.
Sum(Cad)/Alpha HYBOT Hydrogen bonding descriptor – Ca*d factor value per unit of molecular volume
ALOGP Dragon Ghose-Crippen octanol-water partition coefficient
TrnB log P(o/w) –
CHssNH MolconnZ Molecular connectivity descriptor
Sum(Cad)/Alpha HYBOT Hydrogen bonding descriptor – Ca*d factor value per unit of molecular volume
BIC2 Dragon Bond Information Content index (neighbourhood symmetry of 2-order)
Sum(Ea)/Alpha HYBOT Hydrogen bonding descriptor – Ea factor value per unit of molecular volume
Q_VSA_FPPOS MOE Partial charge descriptors – Fractional negative van der Waals surface area. This is the sum of the vi
such that qi is negative divided by the total surface area. The vi are calculated using a connection
table approximation.
ALOGP Dragon Ghose-Crippen octanol-water partition coefficient
ALOGP2 Dragon Squared Ghose-Crippen octanol-water partition coefficient, i.e. (logP)2
NHBint2 HYBOT Atom type electrotopological state: Count of E-State descriptors of strength for potential Hydrogen
Bonds of path length 2.
Sum(Ca)/Alpha HYBOT Hydrogen bonding descriptor – Ca factor value per unit of molecular volume
SIC2 Dragon Information indices – Structural Information Content index (neighbourhood symmetry of 2-order)
E_sol MOE Potential energy descriptor – Solvation energy. In the Potential Setup panel, the term enable flag is
ignored, but the term weight is applied.
PEOE_VSA_FPOS MOE Partial charge descriptor – Fractional positive van der Waals surface area. This is the sum of the vi such
that qi is non-negative divided by the total surface area. The vi are calculated using a connection
table approximation.
Sum(Ead)/Alpha HYBOT Hydrogen bonding descriptor – Ea*d factor value per unit of molecular volume
TrnC CHssNH MolconnZ Molecular connectivity descriptor
Sum(Ea)/Alpha HYBOT Hydrogen bonding descriptor – Ea factor value per unit of molecular volume
PEOE_VSA_FPOS MOE Partial charge descriptor – Fractional positive van der Waals surface area. This is the sum of the vi such
that qi is non-negative divided by the total surface area. The vi are calculated using a connection
table approximation.
Q_VSA_FPPOS MOE Partial charge descriptors – Fractional negative van der Waals surface area. This is the sum of the vi
such that qi is negative divided by the total surface area. The vi are calculated using a connection
table approximation.
MATS1m Dragon 2D autocorrelation – Moran autocorrelation of lag 1 weighted by mass
SHCsatu MolconnZ E-State of Csp3 bonded to unsaturated C atoms
GATS1m Dragon 2D autocorrelation – Geary autocorrelation of lag 1 weighted by mass
Sum(Cad)/Alpha HYBOT Hydrogen bonding descriptor – Ca*d factor value per unit of molecular volume
CHssNH MolconnZ Molecular connectivity descriptor
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provides a more specific molecular basis in determining
specific structural features that contribute positively or neg-
atively to skin permeation.
Figure 6 indicates that a number of the significant
descriptors demonstrate a reasonable correlation. In Fig-
ure 7, it can be seen that, using the MI method, b_1rotR
(the fraction of rotatable single bonds) and b_rotR (the
fraction of rotatable bonds) are highly correlated. The
results of four independent test sets with different descrip-
tor inputs, obtained using the RFT and MI methods
(Table 4) predominately suggest that the best results all
come from the selected descriptors (i.e. using either RFTs
or MI) These results suggest that the two best predictive
models are those which are produced using the feature
selection method to generate the most relevant descriptors
for the data set analysed. The consideration of highly corre-
lated descriptors (Table 5) indicates that statistically
improved models are generated when highly correlated
descriptors, for example b_1rotR and b_rotR, are removed
from the model (that is, only one or the other, not both,
are included in the final model). This highlights the need to
consider the underlying statistical nature of the data and
the potential pitfalls of using highly correlated or covariate
descriptors in models simply because the data and particu-
lar descriptors are easily generated or readily avail-
able.[30,32,36] The consideration of highly correlated
descriptors is shown in Table 5, where the results displayed
are obtained from a MI analysis with and without highly
correlated descriptors. The top line of Table 5 shows data
obtained using six common descriptors, which indicates
that this group of descriptors gives slightly better results
over all test sets. This indicates that the 6-descriptor model
outperforms the 8-descriptor model, yielding a significant
improvement on test sets A and D.
The modelling approach in this study is generally
perceived to be of a ‘top-down’ nature, in that it pro-
vides a gross estimate of skin permeability and, like
related QSAR-type methods, offers limited mechanistic
insight into the permeation process.[36] However, the
addition of feature selection methodologies to this
problem domain in order to precisely determine the
molecular descriptors of interest offers an opportunity
to expand this approach to generate more precise infor-
mation about the membrane permeation process. How-
ever, a practical limitation to this approach is the size
of the data set (n = 77). For example many previous
studies, mostly in the 1990s, examined subsets of skin
permeation generated from Flynn’s data set.[33,65-71] In
many cases, these subsets were focused on specific
molecular properties (such as non-electrolytes[71]) or
specific functional groups.[66,67] One perceived issue
with these studies is that they resulted in poor statisti-
cal fits in many cases, which one might relate to the
small size of the data sets used or, for example, the
Table 3 (Continued)
Training
set Feature list Software Definition
TrnD log P(o/w) –
Sum(Ea)/Alpha HYBOT Hydrogen bonding descriptor – Ea factor value per unit of molecular volume
PEOE_VSA_FPOS MOE Partial charge descriptor – Fractional positive van der Waals surface area. This is the sum of the vi such
that qi is non-negative divided by the total surface area. The vi are calculated using a connection
table approximation.
Sum(Cad)/Alpha HYBOT Hydrogen bonding descriptor – Ca*d factor value per unit of molecular volume
Sum(Ca)/Alpha HYBOT Hydrogen bonding descriptor – Ca factor value per unit of molecular volume
Q_VSA_FPPOS MOE Partial charge descriptors – Fractional negative van der Waals surface area. This is the sum of the vi
such that qi is negative divided by the total surface area. The vi are calculated using a connection
table approximation.
SHCsatu MolconnZ E-State of Csp3 bonded to unsaturated C atoms
E_sol MOE Potential energy descriptor – Solvation energy. In the Potential Setup panel, the term enable flag is
ignored, but the term weight is applied.
Lip_acc MOE The number of O and N atoms
GCUT_SLOGP_1 MOE Adjacency and Distance Matrix Descriptors – The GCUT descriptors using atomic contribution to logP
(using the Wildman and Crippen SlogP method) instead of partial charge
ALOGP Dragon Ghose-Crippen octanol-water partition coeff. (logP)
ALOGP2 Dragon Squared Ghose-Crippen octanol-water partition coeff. (logP)2
BLTA96 Dragon Verhaar Algae base-line toxicity from MLOGP (mmol/l)
NHBint2 HYBOT Atom type electrotopological state: Count of E-State descriptors of strength for potential Hydrogen
Bonds of path length 2.
BIC2 Dragon Bond Information Content index (neighbourhood symmetry of 2-order)
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Figure 6 The correlation coefficient matrix plot for common features selected using RFTs, where var1 to var6 denote, respectively, log Po/w,
PEOE_VSA_FPOS, Q_VSA_FPPOS, CHssNH, Sum(Ea)/Alpha and Sum(Cad)Alpha, respectively. [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 7 The correlation coefficient matrix plot for common features selected using MI, where var1 to var6 denote, respectively, b_1rotR, b_rotR,
log Po/w, Q_VSA_FPPOS, vsurf_A, Max(Ea)*Max(Ed) and Sum(Ea)/Alpha, respectively. [Colour figure can be viewed at wileyonlinelibrary.com]
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absence of methods that can optimise outputs from
small datasets [32]. Thus, while it is possible to specula-
tively identify specific molecular fragments that would
improve permeation models, validation of such models
might be difficult and impractical to develop due to
the size of the data sets involved.
This study raises a novel and highly significant find-
ing in the field of modelling in percutaneous absorp-
tion. Modelling of skin permeation has been shaped
historically by models that used as few as two descrip-
tors and assumptions were subsequently made about
the mechanism of skin permeation that shaped detri-
mentally subsequent developments in this field. It is
known that descriptors such as melting point,
ionisation and hydrogen bonding play a role in skin
permeation. The main point, therefore, of this study
was to propose a methodology that examines as many
descriptors as possible in an unbiased manner and
which then selects the most appropriate descriptors
based on established methods, thus providing a plat-
form for the development of models to predict perme-
ation across, in this case, PDMS membranes. While
such analogies cannot be automatically extended to
fields other than percutaneous absorption, it should be
noted that similar methods have been applied to a
range of biological and environmental endpoints. Thus,
the findings of this study clearly have a wider relevance
beyond percutaneous absorption.
Conclusions
Two sets of molecular descriptors which can provide
improved predictions, compared to the use of either
two descriptors (log P and MW) or a full list of excess
of two thousand descriptors, of permeability across a
PDMS membrane, have been identified (Table 3). Using
the GP method with either of these two sets of descrip-
tors provides significantly better predictions of perme-
ability than using a QSAR model, when compared with
four independent test sets, although the use of such
benchmarks in this study has clear limitations. The gen-
eration of two sets of descriptors echoes previous find-
ings[30] that suggest certain permutations of different
descriptors yield similarly relevant predictive models.
More broadly in the development of reliable, robust
and valid models it is also recommended that highly
correlated descriptors are removed from the data set
when using the GP method. It is also apparent that re-
sampling sub-training sets helps with feature selection
for small data sets, and it is again recommended that
this approach be taken in the development of small
data sets.
The implications of these results for building relevant
predicative models are novel and significant. Models in the
field of percutaneous absorption are based on a small num-
ber of significant descriptors which have been
widely used and often assumed to be relevant based on his-
torical experimental findings. While it has been shown in
this study that some of these descriptors are not relevant,
they are still employed routinely in model development.
This study indicates that this practice should be discontin-
ued and that future predictive models will be improved by
the analysis adopted in this study of the descriptors
employed, rather than simply using any and all available
descriptors or using a smaller set of descriptors whose
choice has been influenced empirically by previously pub-
lished in vitro diffusion studies.













QSAR 19.07 15.64 16.60 14.09
2fs 6.43 16.60 0.52 11.07
Full 7.01 16.11 1.30 10.45
RFTcommon 5.28 14.83 0.23 12.32
MIcommon 4.68 15.36 0.40 8.70
ION
QSAR 150.47 2.89 0.00 34.79
2fs 15.55 3.04 60.43 5.85
Full 0.00 0.00 0.00 0.00
RFTcommon 30.70 7.92 82.18 17.83
MIcommon 38.50 4.62 69.42 16.78
Correlation coefficient
QSAR 0.33 0.61 0.54 0.21
2fs 0.50 0.68 0.80 0.28
Full NaN 0.32 0.06 0.48
RFTcommon 0.84 0.57 0.92 0.18
MIcommon 0.85 0.58 0.83 0.53
NaN indicates that, when using the full set of descriptors, all predic-
tions have a fixed value for this test set, and therefore, the correlation
coefficients cannot be computed; other abbreviations in this table are
as defined in the footnotes of Tables 1 and 2. Results highlighted in
bold are those which achieved the best outcome for each test.
Table 5 Results for ION obtained from RFTs and MI analyses for the
independent test sets with and without highly correlated features










RFT – 6 descriptors 30.70 7.92 82.18 17.83
RFT – 7 descriptors 26.42 5.69 76.43 24.21
MI – 6 descriptors 38.50 4.62 69.42 16.78
MI – 8 descriptors 27.84 1.27 67.64 6.29
Abbreviations in this table are as defined in the footnotes of Tables 1
and 2. Results highlighted in bold are those which achieved the best
outcome for each test.
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